Measles virus: Background and oncolytic virotherapy
- PMID: 29326986
- PMCID: PMC5758921
- DOI: 10.1016/j.bbrep.2017.12.004
Measles virus: Background and oncolytic virotherapy
Abstract
Measles is a highly transmissible disease caused by measles virus and remains a major cause of child mortality in developing countries. Measles virus nucleoprotein (N) encapsidates the RNA genome of the virus for providing protection from host cell endonucleases and for specific recognition of viral RNA as template for transcription and replication. This protein is over-expressed at the time of viral replication. The C-terminal of N protein is intrinsically disordered, which enables this protein to interact with several host cell proteins. It was previously proved in our laboratory that N expressing human cancerous cells undergo programmed cell death because of reactive oxygen species (ROS) generation as well as Caspase 3 activation. The phosphoprotein (P) along with N protein enclosed viral genomic RNA forming a ribonucleoprotein complex (RNP). It also establishes interaction with the large protein (L) i.e. viral RNA dependent RNA polymerase to ensure viral replication within host cells. The host cell receptors of this virus are CD46, SLAM/CD150 and PVRL4. Measles virus is latently oncotropic in nature and possesses oncolytic property by syncytia formation. We try to highlight the application of this property in developing a virotherapeutic vehicle.
Keywords: CD46 (cluster of differentiation 46); Edmonston vaccine strain; Measles virus; Oncotropic and oncolytic viruses; Syncytia.
Figures
Similar articles
-
Measles virus phosphoprotein inhibits apoptosis and enhances clonogenic and migratory properties in HeLa cells.J Biosci. 2019 Mar;44(1):10. J Biosci. 2019. PMID: 30837361
-
The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein.Viruses. 2016 Sep 20;8(9):250. doi: 10.3390/v8090250. Viruses. 2016. PMID: 27657109 Free PMC article. Review.
-
Measles to the Rescue: A Review of Oncolytic Measles Virus.Viruses. 2016 Oct 22;8(10):294. doi: 10.3390/v8100294. Viruses. 2016. PMID: 27782084 Free PMC article. Review.
-
Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.PLoS Pathog. 2011 Aug;7(8):e1002240. doi: 10.1371/journal.ppat.1002240. Epub 2011 Aug 25. PLoS Pathog. 2011. PMID: 21901103 Free PMC article.
-
Enhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150/signaling lymphocytic activation molecule.Cancer Sci. 2014 Feb;105(2):211-8. doi: 10.1111/cas.12324. Epub 2014 Jan 12. Cancer Sci. 2014. PMID: 24238277 Free PMC article.
Cited by
-
Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses.Front Immunol. 2022 Oct 13;13:1012806. doi: 10.3389/fimmu.2022.1012806. eCollection 2022. Front Immunol. 2022. PMID: 36311790 Free PMC article. Review.
-
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.Int J Mol Sci. 2021 Feb 24;22(5):2259. doi: 10.3390/ijms22052259. Int J Mol Sci. 2021. PMID: 33668361 Free PMC article. Review.
-
Persistent Infection of a Canine Histiocytic Sarcoma Cell Line with Attenuated Canine Distemper Virus Expressing Vasostatin or Granulocyte-Macrophage Colony-Stimulating Factor.Int J Mol Sci. 2022 May 31;23(11):6156. doi: 10.3390/ijms23116156. Int J Mol Sci. 2022. PMID: 35682834 Free PMC article.
-
The Communication between Ocular Surface and Nasal Epithelia in 3D Cell Culture Technology for Translational Research: A Narrative Review.Int J Mol Sci. 2021 Nov 30;22(23):12994. doi: 10.3390/ijms222312994. Int J Mol Sci. 2021. PMID: 34884799 Free PMC article. Review.
-
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.Signal Transduct Target Ther. 2022 Apr 6;7(1):117. doi: 10.1038/s41392-022-00951-x. Signal Transduct Target Ther. 2022. PMID: 35387984 Free PMC article. Review.
References
-
- Biesbroeck L. Viral exanthems: an update. Dermatol. Ther. 2013;26(6):433–438. - PubMed
-
- Ludlow M. Pathological consequences of systemic measles virus infection. J. Pathol. 2015;235(2):253–265. - PubMed
-
- Leuridan E. Measles outbreak in Europe: susceptibility of infants too young to be immunized. Vaccine. 2012;30(41):5905–5913. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials